08:03 AM EDT, 07/29/2025 (MT Newswires) -- Kiniksa Pharmaceutical (KNSA) reported Q2 earnings Tuesday of $0.23 per diluted share, swinging from a loss of $0.06 a year earlier.

Analysts polled by FactSet expected EPS of $0.22.

Total revenue for the quarter ended June 30 was $156.8 million compared with $108.6 million a year earlier.

Analysts surveyed by FactSet expected $146.5 million.

Shares of the company were up nearly 19% in Tuesday's premarket activity.